THIOPHENDERIVATE

Patent europeic · EP3793989 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3793989
Numer da la dumonda
EP19723796
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
15-05-2019
Publitgà
24-03-2021
Concedì
21-08-2024
La protecziun finescha il pli tard
14-05-2039
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
C07D 333/72 (2006.01)
C07D 333/78 (2006.01)
C07D 409/04 (2006.01)
A61P 35/00 (2006.01)
A61K 31/381 (2006.01)
Prioritad
EP 18173069 18.05.2018
Dumonda PCT
PCT/EP2019/062438 15.05.2019
Publicaziun PCT
WO2019/219731 21.11.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 02-07-2025

    Midada

    Published in Swissreg on 02.07.2025

  3. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  4. 21-08-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.08.2024

Partidas

Possessur

Merck Patent GmbH

Frankfurter Strasse 250, 64293 Darmstadt, DE

Ryvu Therapeutics S.A.

ul. Bobrzynskiego 14, 30-348 Krakow, PL

Inventur

BUCHSTALLER, Hans-Peter

64347 GRIESHEIM, DE

MATTHIAS, Leiendecker

64293 Darmstadt, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.